Scientists Fear Meningitis B Mutation Behind Rapid Spread in Kent Outbreak
Top scientists are raising alarms that a mutation in the deadly meningitis B strain could be responsible for a major outbreak in Kent, as the number of confirmed cases has risen to 29. This development has sparked concerns that the bacteria may have evolved to spread more easily, challenging previous understanding of its transmission patterns.
Unusual Transmission Patterns Raise Concerns
UK Health Security Agency doctors have confirmed that at least 13 of the 29 cases connected to the current outbreak belong to the meningitis B strain, a particularly dangerous bacterial form of the infection. In Britain, menB typically appears in only a few isolated cases annually, as it usually requires close, direct, and prolonged contact to spread between individuals.
However, the cluster of infections linked to a nightclub in Canterbury has reignited long-held fears among scientists that menB might be mutating to increase its transmission rate. Professor Robin May, chief scientific officer at the UKHSA, explained to BBC Breakfast how this outbreak differs from previous patterns.
"Typically, you would expect to see sporadic cases of meningitis, typically individual patients. Most days, actually, we would see one in the UK. This is obviously a much larger number," Professor May stated. "What is particularly remarkable about this case, and unexpected about this case, is the large number of cases all originating from what seems to be a single event."
Two Possible Explanations for the Outbreak
Professor May outlined two potential reasons for the unusual spread pattern. "There are two possible reasons for that. One is that there might be something about the kind of behaviours that individual people are doing. The other possibility is the bacteria itself may have evolved to be better at transmitting."
The scientific community is particularly concerned about the latter possibility, as it would represent a significant shift in the epidemiology of this dangerous infection. While viral meningitis, specifically the menC strain, was once the leading cause of cases in the United Kingdom, the introduction of a vaccine in the 1990s reduced annual cases by approximately 96%.
Vaccination Gaps Leave Students Vulnerable
Schoolchildren in Britain currently receive the MenACWY vaccine during Year 9, with free "catch-up" doses available for anyone who missed it up to age 25. However, this vaccine provides protection against types A, C, W and Y, but not against menB.
A separate MenB vaccine was added to the NHS immunisation schedule for infants 11 years ago, offering protection for babies and young children. However, anyone born before May 1, 2015, did not receive this vaccine, creating what experts describe as an "immunity gap" among current students and adolescents over age 11.
Dr Eliza Gil, Clinical Lecturer at the London School of Hygiene & Tropical Medicine, explained this vulnerability: "It's unlikely that these students will have protective immunity to meningitis B. The meningitis B vaccination has been recommended and offered to babies in the UK from 2015. This means that it is the strain that many current students will not have been vaccinated against."
Targeted Protection Leaves Gaps
The MenB vaccine is specifically administered to babies because they represent the group at highest risk of death or serious illness from the infection. "This has been a deliberate decision to protect the most vulnerable," Dr Gil noted. "But unfortunately, this does mean that many current students won't have immunity to meningitis B themselves."
Students are not routinely offered MenB vaccination because their risk has traditionally been low compared to young children and babies. Additionally, the protection offered by the vaccine is imperfect and believed to last only a few years.
Despite this, affected patients and their families, alongside charities and organizations such as the National Union of Students, have actively campaigned for broader access to the vaccine. Some individuals are already obtaining the vaccine through private healthcare providers.
Health Secretary Wes Streeting recently visited the University of Kent campus in Canterbury, where 5,000 students have been offered vaccines in response to the outbreak. The situation continues to develop as scientists work to understand whether behavioural factors or bacterial evolution is driving this unusual cluster of meningitis B cases.
